Denna sida finns för närvarande inte på ditt språk. Du kan
med Google Translate. Vi ansvarar inte för att tillhandahålla denna tjänst och
vi har inte kontrollerat översättningsresultaten.
Kontakta oss om du behöver ytterligare hjälp.
Statement of Clarification
15 January 2014
It has recently come to our attention that Medtech SA, based in France, has repeatedly made public statements that Medtech is the only European company that designs and sells neurosurgical robots.
This statement is incorrect. Renishaw Mayfield (part of the Renishaw Group, headed by
Renishaw plc) designs and manufactures its neurosurgical robot, the NeuroMate®, in Europe. The NeuroMate is manufactured in Lyon, France. R&D is undertaken in France and in the UK, with sales and clinical service offices based in Switzerland.
The NeuroMate holds a significant market share of installed neurosurgical robots globally (over 30 robots worldwide including 7 robots currently in use at top neurosurgical centres in France) and has been cited in more than 30 published peer-reviewed scientific journal articles.
While we welcome healthy competition, which we believe encourages innovation, we have released this statement to ensure that accurate information is provided to the public.
- Statement of Clarification [94kB]
- Neuromate surgical robot [682kB]
All images and text copyright Renishaw
Register for news updates
Register for regular news updates from Renishaw